Cargando…

Sex-specific associations of matrix metalloproteinases in Alzheimer’s disease

INTRODUCTION: Alzheimer’s disease (AD) can be characterised in vivo by biomarkers reflecting amyloid-β (Aβ) and tau pathology. However, there is a need for biomarkers reflecting additional pathological pathways. Matrix metalloproteinases (MMPs) have recently been highlighted as candidate biomarkers...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aksnes, Mari, Edwin, Trine H., Saltvedt, Ingvild, Eldholm, Rannveig S., Chaudhry, Farrukh A., Halaas, Nathalie B., Myrstad, Marius, Watne, Leiv O., Knapskog, Anne-Brita
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207710/ https://www.ncbi.nlm.nih.gov/pubmed/37221606 http://dx.doi.org/10.1186/s13293-023-00514-x

Ejemplares similares

Cerebrospinal fluid catecholamines in Alzheimer’s disease patients with and without biological disease
por: Henjum, Kristi, et al.
Publicado: (2022)

A high cerebrospinal fluid soluble TREM2 level is associated with slow clinical progression of Alzheimer's disease
por: Edwin, Trine Holt, et al.
Publicado: (2020)

Cerebrospinal fluid sTREM2 in Alzheimer’s disease: comparisons between clinical presentation and AT classification
por: Knapskog, Anne-Brita, et al.
Publicado: (2020)

Factors that influence the levels of cerebrospinal fluid biomarkers in memory clinic patients
por: Knapskog, Anne-Brita, et al.
Publicado: (2017)

Association between vascular comorbidity and progression of Alzheimer’s disease: a two-year observational study in Norwegian memory clinics
por: Eldholm, Rannveig Sakshaug, et al.
Publicado: (2018)

MRI-assessed atrophy subtypes in Alzheimer’s disease and the cognitive reserve hypothesis
por: Persson, Karin, et al.
Publicado: (2017)

The Impact of Vascular Risk Factors on Post-stroke Cognitive Impairment: The Nor-COAST Study
por: Aam, Stina, et al.
Publicado: (2021)

Comparison of Cerebrospinal Fluid Amyloidogenic Nanoplaques With Core Biomarkers of Alzheimer’s Disease
por: Aksnes, Mari, et al.
Publicado: (2021)

Associations of cerebrospinal fluid amyloidogenic nanoplaques with cytokines in Alzheimer’s disease
por: Aksnes, Mari, et al.
Publicado: (2021)

Amyloidogenic Nanoplaques in Cerebrospinal Fluid: Relationship to Amyloid Brain Uptake and Clinical Alzheimer’s Disease in a Memory Clinic Cohort
por: Aksnes, Mari, et al.
Publicado: (2020)

Cerebrospinal fluid quinolinic acid is strongly associated with delirium and mortality in hip-fracture patients
por: Watne, Leiv Otto, et al.
Publicado: (2023)

Serum Amyloidogenic Nanoplaques and Cytokines in Alzheimer’s Disease: Pilot Study in a Small Naturalistic Memory Clinic Cohort
por: Aksnes, Mari, et al.
Publicado: (2022)

Is Amyloid Burden Measured by (18)F-Flutemetamol PET Associated with Progression in Clinical Alzheimer’s Disease?
por: Müller, Ebba Gløersen, et al.
Publicado: (2022)

Cerebrospinal Fluid S100B and Alzheimer's Disease Biomarkers in Hip Fracture Patients with Delirium
por: Hov, Karen Roksund, et al.
Publicado: (2017)

The effect of a pre- and post-operative orthogeriatric service on cognitive function in patients with hip fracture. The protocol of the Oslo Orthogeriatrics Trial
por: Wyller, Torgeir Bruun, et al.
Publicado: (2012)

Post-stroke Cognitive Impairment—Impact of Follow-Up Time and Stroke Subtype on Severity and Cognitive Profile: The Nor-COAST Study
por: Aam, Stina, et al.
Publicado: (2020)

Orthogeriatrics prevents functional decline in hip fracture patients: report from two randomized controlled trials
por: Dakhil, Shams, et al.
Publicado: (2021)

Brain Morphometric Correlates of Depressive Symptoms among Patients with and without Dementia
por: Barca, Maria Lage, et al.
Publicado: (2022)

Amyloid-β PET—Correlation with cerebrospinal fluid biomarkers and prediction of Alzheimer´s disease diagnosis in a memory clinic
por: Müller, Ebba Gløersen, et al.
Publicado: (2019)

Longitudinal trajectories of functional recovery after hip fracture
por: Dakhil, Shams, et al.
Publicado: (2023)

Investigating novel biomarkers of immune activation and modulation in the context of sedentary behaviour: a multicentre prospective ischemic stroke cohort study
por: Alme, Katinka Nordheim, et al.
Publicado: (2021)

Neopterin and kynurenic acid as predictors of stroke recurrence and mortality: a multicentre prospective cohort study on biomarkers of inflammation measured three months after ischemic stroke
por: Alme, Katinka Nordheim, et al.
Publicado: (2021)

Matrix Metalloproteinases and Their Multiple Roles in Alzheimer's Disease
por: Wang, Xiang-Xiang, et al.
Publicado: (2014)

The effect of a pre- and postoperative orthogeriatric service on cognitive function in patients with hip fracture: randomized controlled trial (Oslo Orthogeriatric Trial)
por: Watne, Leiv Otto, et al.
Publicado: (2014)

Slc38a1 Conveys Astroglia-Derived Glutamine into GABAergic Interneurons for Neurotransmitter GABA Synthesis
por: Qureshi, Tayyaba, et al.
Publicado: (2020)

Results after introduction of a hip fracture care pathway: comparison with usual care
por: Svenøy, Stian, et al.
Publicado: (2020)

Time from dementia diagnosis to nursing-home admission and death among persons with dementia: A multistate survival analysis
por: Mjørud, Marit, et al.
Publicado: (2020)

Study protocol: ASCRIBED: the impact of Acute SystematiC inflammation upon cerebRospinal fluId and blood BiomarkErs of brain inflammation and injury in dementia: a study in acute hip fracture patients
por: Leavey, Nick, et al.
Publicado: (2019)

Increased CSF levels of aromatic amino acids in hip fracture patients with delirium suggests higher monoaminergic activity
por: Watne, Leiv Otto, et al.
Publicado: (2016)

The Norwegian Cognitive impairment after stroke study (Nor-COAST): study protocol of a multicentre, prospective cohort study
por: Thingstad, Pernille, et al.
Publicado: (2018)

Matrix metalloproteinase 13, a new target for therapy in Alzheimer's disease
por: Paumier, Jean-Michel, et al.
Publicado: (2019)

Functional relationship between matrix metalloproteinase-11 and matrix metalloproteinase-14
por: Buache, Emilie, et al.
Publicado: (2014)

Expression of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases in the hair cycle
por: HOU, CHUN, et al.
Publicado: (2016)

Pre-stroke cognitive impairment is associated with vascular imaging pathology: a prospective observational study
por: Schellhorn, Till, et al.
Publicado: (2021)

CSF sTREM2 in delirium—relation to Alzheimer’s disease CSF biomarkers Aβ42, t-tau and p-tau
por: Henjum, Kristi, et al.
Publicado: (2018)

Associations between post-stroke motor and cognitive function: a cross-sectional study
por: Einstad, Marte Stine, et al.
Publicado: (2021)

Matrix metalloproteinases and epileptogenesis
por: Ikonomidou, Chrysanthy
Publicado: (2014)

Matrix Metalloproteinases and Glaucoma
por: Kim, Moo Hyun, et al.
Publicado: (2022)

The association of high sensitivity C-reactive protein and incident Alzheimer disease in patients 60 years and older: The HUNT study, Norway
por: Gabin, Jessica Mira, et al.
Publicado: (2018)

Alterations of matrix metalloproteinases in the healthy elderly with increased risk of prodromal Alzheimer's disease
por: Stomrud, Erik, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_mk0usj7as6ihjqstguflq8i06k